Literature DB >> 17826372

Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction.

Stijntje D Roes1, Sebastian Kelle, Theodorus A M Kaandorp, Thomas Kokocinski, Don Poldermans, Hildo J Lamb, Eric Boersma, Ernst E van der Wall, Eckart Fleck, Albert de Roos, Eike Nagel, Jeroen J Bax.   

Abstract

Currently, left ventricular (LV) ejection fraction (EF) and/or LV volumes are the established predictors of mortality in patients with coronary artery disease (CAD) and severe LV dysfunction. With contrast-enhanced magnetic resonance imaging (MRI), precise delineation of infarct size is now possible. The relative merits of LVEF/LV volumes and infarct size to predict long-term outcome are unknown. The purpose of this study was to determine the predictive value of infarct size assessed with contrast-enhanced MRI relative to LVEF and LV volumes for long-term survival in patients with healed myocardial infarction. Cine MRI and contrast-enhanced MRI were performed in 231 patients with healed myocardial infarction. LVEF and LV volumes were measured and infarct size was derived from contrast-enhanced MRI. Nineteen patients (8.2%) died during a median follow-up of 1.7 years (interquartile range 1.1 to 2.9). Cox proportional hazards analysis revealed that infarct size defined as spatial extent (hazard ratio [HR] 1.3, 95% confidence interval [CI] 1.1 to 1.6, chi-square 6.7, p=0.010), transmurality (HR 1.5, 95% CI 1.1 to 1.9, chi-square 8.9, p=0.003), or total scar score (HR 6.2, 95% CI 1.7 to 23, chi-square 7.4, p=0.006) were stronger predictors of all-cause mortality than LVEF and LV volumes. In conclusion, infarct size on contrast-enhanced MRI may be superior to LVEF and LV volumes for predicting long-term mortality in patients with healed myocardial infarction.

Entities:  

Mesh:

Year:  2007        PMID: 17826372     DOI: 10.1016/j.amjcard.2007.04.029

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  60 in total

1.  Reliability of myocardial salvage assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarction.

Authors:  Steffen Desch; Hubertus Engelhardt; Josefine Meissner; Ingo Eitel; Mahdi Sareban; Georg Fuernau; Suzanne de Waha; Matthias Grothoff; Matthias Gutberlet; Gerhard Schuler; Holger Thiele
Journal:  Int J Cardiovasc Imaging       Date:  2011-01-30       Impact factor: 2.357

2.  Reperfusion injury components and manifestations determined by cardiovascular MR and MDCT imaging.

Authors:  Maythem Saeed; Steve Hetts; Mark Wilson
Journal:  World J Radiol       Date:  2010-01-28

3.  Prediction of long-term reverse left ventricular remodeling after revascularization or medical treatment in patients with ischemic cardiomyopathy: a comparative study between SPECT and MRI.

Authors:  Tomas Skala; Martin Hutyra; Jan Vaclavik; Milan Kaminek; David Horak; Josef Novotny; Jana Zapletalova; Jan Lukl; Dan Marek; Milos Taborsky
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-20       Impact factor: 2.357

4.  Head to head comparison of quantitative versus visual analysis of contrast CMR in the setting of myocardial stunning after STEMI: implications on late systolic function and patient outcome.

Authors:  Oliver Husser; Vicente Bodi; Juan Sanchis; Julio Nunez; Luis Mainar; Pilar Merlos; Maria P Lopez-Lereu; Jose V Monmeneu; Fabian Chaustre; Eva Rumiz; Günter A J Riegger; Francisco J Chorro; Angel Llacer
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-20       Impact factor: 2.357

Review 5.  The cardiac magnetic resonance (CMR) approach to assessing myocardial viability.

Authors:  Andrew E Arai
Journal:  J Nucl Cardiol       Date:  2011-12       Impact factor: 5.952

6.  Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers.

Authors:  Yibo Ling; Terrence Pong; Christophoros C Vassiliou; Paul L Huang; Michael J Cima
Journal:  Nat Biotechnol       Date:  2011-02-13       Impact factor: 54.908

7.  Viability assessment with MRI is superior to FDG-PET for viability: Pro.

Authors:  Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

Review 8.  Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI.

Authors:  Pier Giorgio Masci; Jan Bogaert
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

9.  Clinical applications for cardiovascular magnetic resonance imaging at 3 tesla.

Authors:  Allison G Hays; Michael Schär; Sebastian Kelle
Journal:  Curr Cardiol Rev       Date:  2009-08

Review 10.  Quantification in cardiac MRI: advances in image acquisition and processing.

Authors:  Anil K Attili; Andreas Schuster; Eike Nagel; Johan H C Reiber; Rob J van der Geest
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.